Anastrozole

• Post Date:

  Jun 08,2015

• Expiry Date:

  Dec 05,2015

• Detailed Description:

  Cas No. :120511-73-1 Anastrozole(Arimidex)
  CAS No： 120511-73-1
  Molecular formula： 120511-73-1
  Molecular weight： 293.37
  Appearance： White powder.
  Assay： 99%
  Delivery time： 5-7 business days door-to-door
  Minimum order： 1g
  Supply ability： 10kg per mouth
  Quality standard： USP 35 Product details:
  Anastrozole is an aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for
  
  metastasis in both pre and postmenopausal women. The severity of breast cancer is increased by estrogen, as sexhormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen.
  
  The trial suggested that anastrozole is the preferred medical therapy for Postmenopausal women with localized breast cancer that is estrogen receptor (ER) positive.
  
  Three azole potent selective aromatase inhibitors, which inhibit rely on aromatase cytochrome P -450 to block
  
  estrogen biosynthesis, and the main factors of estrogen to stimulate breast cancer cell growth. It can treat breast cancer, especially suitable for those who relapse after treatment with hormone auxiliary advanced breast cancer after menopause women.

• CAS Registry Number:

  120511-73-1

• Synonyms:

  ;Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile;ICI-D-1033;Arimidex;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha',alpha'-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-;Anastrozol;Anatrozole;ZD-1033, ICI-D-1033, Arimidex;2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile;1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)- zd;1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl);2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile);

• Molecular Formula:

  C₁₇H₁₉N₅

• Molecular Weight:

  293.37

• Molecular Structure:

  

• Company:

  Hugeraw Health Technology Co.,Ltd.     [ China ]        

• Contact:

  mandy hu

• Tel:

  +86-523-51904695

• Fax:

  +86-523-51904698

• Email:

  hugerawmandy@hotmail.com